RACEMIC-2-((3R,3AR,7AR)-5-(TERT-BUTOXYCARBONYL)OCTAHYDROFURO[3,4-C]PYRIDIN-3-YL)ACETIC ACID

Catalog No.: 
ACPKDM786
CAS No.: 
2177266-38-3
Molecular Formula: 
C14H23NO5
Molecular Weight: 
285.34
RACEMIC-2-((3R,3AR,7AR)-5-(TERT-BUTOXYCARBONYL)OCTAHYDROFURO[3,4-C]PYRIDIN-3-YL)ACETIC ACID structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$4812.00InquiryInquiry
100mg95%$6015.00InquiryInquiry
250mg95%$8422.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRACEMIC-2-((3R,3AR,7AR)-5-(TERT-BUTOXYCARBONYL)OCTAHYDROFURO[3,4-C]PYRIDIN-3-YL)ACETIC ACID
IUPAC Name2-((3S,3aR,7aR)-5-(tert-butoxycarbonyl)octahydrofuro[3,4-c]pyridin-3-yl)acetic acid
MDL No.MFCD21362275
Molecular FormulaC14H23NO5
Molecular Weight285.34
SMILESO=C(N1C[C@@H]2[C@H](CC(O)=O)OC[C@@H]2CC1)OC(C)(C)C
InChI KeyHYKLGHFHJLHTNN-DCAQKATOSA-N
SynonymFuro[3,4-c]pyridine-3-acetic acid, 5-[(1,1-dimethylethoxy)carbonyl]octahydro-, (3R,3aS,7aS)-rel-
CAS No.2177266-38-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPKDM786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPKDM786 route product structure diagram
    ACPKDM7862177266-38-3
Inquiry

2. ACPKDM786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPKDM786 route product structure diagram
    ACPKDM7862177266-38-3
Inquiry

3. ACPKDM786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPKDM786 route product structure diagram
    ACPKDM7862177266-38-3
Inquiry

Comments (0)